KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Jan 29, 2026 >>  ABB India 5475.9  [ 8.52% ]  ACC 1677.7  [ -0.46% ]  Ambuja Cements 536  [ 0.39% ]  Asian Paints 2416.7  [ -3.75% ]  Axis Bank 1364.35  [ 3.32% ]  Bajaj Auto 9507.75  [ 0.77% ]  Bank of Baroda 302.5  [ -1.19% ]  Bharti Airtel 1968.15  [ 0.57% ]  Bharat Heavy 260.4  [ 0.29% ]  Bharat Petroleum 366.9  [ 1.24% ]  Britannia Industries 5725.55  [ -0.34% ]  Cipla 1320.35  [ -0.59% ]  Coal India 455.9  [ 2.62% ]  Colgate Palm 2111.85  [ -1.94% ]  Dabur India 508.6  [ -1.37% ]  DLF 638.3  [ 2.06% ]  Dr. Reddy's Labs 1208.45  [ -1.29% ]  GAIL (India) 167.3  [ -0.48% ]  Grasim Industries 2832.95  [ -0.35% ]  HCL Technologies 1721.15  [ -0.53% ]  HDFC Bank 935.65  [ 0.32% ]  Hero MotoCorp 5576.9  [ 1.38% ]  Hindustan Unilever 2351.65  [ -1.21% ]  Hindalco Industries 1024.8  [ 2.61% ]  ICICI Bank 1384.1  [ 1.22% ]  Indian Hotels Co. 664.6  [ 1.26% ]  IndusInd Bank 898.1  [ -0.37% ]  Infosys 1657.7  [ -0.52% ]  ITC 318.65  [ -0.81% ]  Jindal Steel 1155.2  [ 3.23% ]  Kotak Mahindra Bank 412.35  [ -0.01% ]  L&T 3932.45  [ 3.66% ]  Lupin 2131.8  [ 0.48% ]  Mahi. & Mahi 3385.5  [ -1.83% ]  Maruti Suzuki India 14499.5  [ -2.54% ]  MTNL 30.81  [ -1.57% ]  Nestle India 1287.75  [ -0.38% ]  NIIT 75.9  [ 0.78% ]  NMDC 84.7  [ 3.91% ]  NTPC 358.1  [ 2.84% ]  ONGC 275.25  [ 2.46% ]  Punj. NationlBak 125.2  [ 0.56% ]  Power Grid Corpo 260.55  [ 0.31% ]  Reliance Industries 1391.9  [ -0.37% ]  SBI 1064.5  [ 0.16% ]  Vedanta 766.1  [ 3.93% ]  Shipping Corpn. 222.35  [ 0.82% ]  Sun Pharmaceutical 1589.3  [ -1.29% ]  Tata Chemicals 723.45  [ -0.52% ]  Tata Consumer Produc 1106.2  [ -2.29% ]  Tata Motors Passenge 351.85  [ 3.35% ]  Tata Steel 202.35  [ 4.41% ]  Tata Power Co. 366.4  [ 3.20% ]  Tata Consultancy 3146.1  [ -1.68% ]  Tech Mahindra 1767.8  [ 0.30% ]  UltraTech Cement 12719.5  [ -0.39% ]  United Spirits 1330.9  [ 0.27% ]  Wipro 239.85  [ 1.03% ]  Zee Entertainment En 82.98  [ -1.18% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

INFINIUM PHARMACHEM LTD.

29 January 2026 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE0MRE01011 BSE Code / NSE Code / Book Value (Rs.) 81.31 Face Value 10.00
Bookclosure 13/09/2023 52Week High 337 EPS 5.85 P/E 36.96
Market Cap. 301.01 Cr. 52Week Low 210 P/BV / Div Yield (%) 2.66 / 0.00 Market Lot 500.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
The Company was originally incorporated as Private Limited, under the Companies Act, 1956 ("Companies Act") in the name and style of "M/s Infinium Pharmachem Private Limited" on November 21st, 2003 under the provisions of the Companies Act, 1956 vide Certificate of Incorporation issued by the Registrar of Companies, Ahmedabad, Gujarat. Later on, company was converted into public limiteds company, the name of the Company was changed to "Infinium Pharmachem Limited" and fresh Certificate of Incorporation dated August 12th, 2022 was issued by the Registrar of Companies, Ahmedabad, Gujarat.

Infinium Pharmachem Limited, well focused to Iodine chemistry & this is the only core area of ours. We are working as CRAMS, but the domain is very restricted to Iodine chemistry & it revolves around Iodine derivatives or Iodination. The company also providing fully integrated customized services from R & D to Commercial scale manufacturing and packaging for our products to the Pharmaceutical, Agrochemical,Nutraceutical, Speciality Chemicals & various other chemical Industries.The supply range of Iodine derivatives on Order to Made basis only. However, we keep in ready stock many of well demanded products. MAJOR EVENTS : 2003 - Established with a vision to be a globally integrated and admired Pharmaceutical and Healthcare Company. 2004 -Started iodine derivatives manufacturing plant at Gujarat, India. 2010 -Set up R & D Unit and Certified as ISO 90001-2008. 2011 - Penetrated the Pharmaceutical market with the CRAMS model. 2014 - Upgraded Plant with GMP compliant large scale manufacturing facility. 2015 -Obtained FDA approval for manufacturing of APIs. 2017 -Certified as WHO-GMP and ISO 14001-2015. 2018 -Product Portfolio touched 200+ Iodine Derivatives and 7+ APIs. 2019 -Expanded reach to over 15+ countries across the globe. 2021 -Augmentation of production capacity and construction of new Premises. 2022 - Incorporated subsidiary company in bio-fuel segment for backwar 2023 -The Company has issued Bonus Shares in the Ratio of 1:1. - 'Commencement Of Production By Subsidiary Company'. 

2024 
-Infinium Pharmachem Ltd CommencesConstruction of New Project for manufacturing Contrast Media Raw Materials. 
-Infinium Pharmachem Limited has informed the Exchange about Acquisition of equity shares of Infinium Healthcare Private Limited.